Johnson Pharmacare Ltd Stock Price Today (NSE: JOHNPHARMA)
Fundamental Score
Johnson Pharmacare Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Johnson Pharmacare Ltd share price today is ₹0.56, up +0.00% on NSE/BSE as of 20 February 2026. Johnson Pharmacare Ltd (JOHNPHARMA) is a Small-cap company in the Diversified Commercial Services sector with a market capitalisation of ₹33.00 (Cr). The 52-week high for JOHNPHARMA share price is ₹N/A and the 52-week low is ₹N/A. The company has a Return on Equity (ROE) of -0.44% and a debt-to-equity ratio of 0.02.
Johnson Pharmacare Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Johnson Pharmacare Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Johnson Pharmacare Share Price: A Value Investor's Cautious Perspective
For the conservative value investor, navigating the diversified commercial services sector requires careful scrutiny. Often, these businesses operate with limited barriers to entry, demanding exceptional management and robust profitability. Analyzing the Johnson Pharmacare share price necessitates a focus on capital safety above all else. At a price of ₹0.6, the absence of a Price-to-Earnings (PE) ratio is immediately concerning, often indicating a lack of consistent profitability. Our preliminary assessment, part of a larger 80-parameter fundamental audit verified by Sweta Mishra, reveals potential red flags.
A critical metric for value investors is Return on Capital Employed (ROCE). Johnson Pharmacare Ltd.'s ROCE of -0.43% is deeply concerning. This negative figure suggests the company is destroying capital, failing to generate returns from its invested capital. This significantly weakens any potential economic "moat" – the company's ability to protect its profitability and market share. A strong moat is crucial for long-term value creation, and its absence makes the investment proposition highly speculative.
When compared with sector peers, such as
Nirmitee Robotics India Ltd, a stark contrast may emerge, particularly regarding management quality and strategic execution. While a detailed comparison of Nirmitee Robotics is beyond the scope of this focused analysis, it's essential for a thorough evaluation to examine how Johnson Pharmacare's management compares to its peers in terms of capital allocation decisions and operational efficiency. Different levels of efficiency can easily be observed in the current market.Given the negative ROCE and the lack of a PE ratio, our observational analysis suggests extreme caution. The focus for a value investor prioritizing capital safety should be on deeply understanding the reasons behind the poor performance and assessing the likelihood of a turnaround. Further investigation into the company's debt levels, cash flow, and competitive landscape is warranted before considering any investment decision. This analysis is purely observational and does not constitute investment advice.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Johnson Pharmacare Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of JOHNPHARMA across key market metrics for learning purposes.
Positive Indicators
2 factors identified
Conservative Debt Levels (D/E: 0.02)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
4 factors identified
Below-Average Return on Equity (-0.44%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-0.43%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Low Promoter Commitment (0.00%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Johnson Pharmacare Ltd Financial Statements
Comprehensive financial data for Johnson Pharmacare Ltd including income statement, balance sheet and cash flow
About JOHNPHARMA (Johnson Pharmacare Ltd)
Johnson Pharmacare Ltd (JOHNPHARMA) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Diversified Commercial Services sector with a current market capitalisation of ₹33.00 (Cr). Johnson Pharmacare Ltd has delivered a Return on Equity (ROE) of -0.44% and a ROCE of -0.43%. The debt-to-equity ratio stands at 0.02, reflecting the company's capital structure. Investors tracking JOHNPHARMA share price can monitor key metrics including P/E ratio, promoter holding of 0.00%, and quarterly earnings growth.
Company Details
Key Leadership
JOHNPHARMA Share Price: Frequently Asked Questions
What is the current share price of Johnson Pharmacare Ltd (JOHNPHARMA)?
As of 20 Feb 2026, 05:04 am IST, Johnson Pharmacare Ltd share price is ₹0.56. The JOHNPHARMA stock has a market capitalisation of ₹33.00 (Cr) on NSE/BSE.
Is JOHNPHARMA share price Overvalued or Undervalued?
JOHNPHARMA share price is currently trading at a P/E ratio of 0.00x, compared to the industry average of 23.64x. Based on this relative valuation, the Johnson Pharmacare Ltd stock appears to be Fairly Valued against its sector peers.
What is the 52-week high and low of JOHNPHARMA share price?
The 52-week high of JOHNPHARMA share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Johnson Pharmacare Ltd share price?
Key factors influencing JOHNPHARMA share price include quarterly earnings growth (Sales Growth: N/A%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Johnson Pharmacare Ltd a good stock for long-term investment?
Johnson Pharmacare Ltd shows a 5-year Profit Growth of N/A% and an ROE of -0.44%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.02 before investing in JOHNPHARMA shares.
How does Johnson Pharmacare Ltd compare with its industry peers?
Johnson Pharmacare Ltd competes with major peers in the Diversified Commercial Services. Investors should compare JOHNPHARMA share price P/E of 0.00x and ROE of -0.44% against the industry averages to determine competitive standing.
What is the P/E ratio of JOHNPHARMA and what does it mean?
JOHNPHARMA share price has a P/E ratio of N/Ax compared to the industry average of 23.64x. Investors pay ₹N/A for every ₹1 of annual earnings.
How is JOHNPHARMA performing according to Bull Run's analysis?
JOHNPHARMA has a Bull Run fundamental score of N/A/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does JOHNPHARMA belong to?
JOHNPHARMA operates in the Diversified Commercial Services industry. This classification helps understand the competitive landscape and sector-specific trends affecting Johnson Pharmacare Ltd share price.
What is Return on Equity (ROE) and why is it important for JOHNPHARMA?
JOHNPHARMA has an ROE of -0.44%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Johnson Pharmacare Ltd generates profits from shareholders capital.
How is JOHNPHARMA debt-to-equity ratio and what does it indicate?
JOHNPHARMA has a debt-to-equity ratio of 0.02, which indicates conservative financing with low financial risk.
What is JOHNPHARMA dividend yield and is it a good dividend stock?
JOHNPHARMA offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Johnson Pharmacare Ltd shares.
How has JOHNPHARMA share price grown over the past 5 years?
JOHNPHARMA has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in JOHNPHARMA and why does it matter?
Promoters hold 0.00% of JOHNPHARMA shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Johnson Pharmacare Ltd.
What is JOHNPHARMA market capitalisation category?
JOHNPHARMA has a market capitalisation of ₹33 crores, placing it in the Small-cap category.
How volatile is JOHNPHARMA stock?
JOHNPHARMA has a beta of N/A. A beta > 1 suggests the Johnson Pharmacare Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is JOHNPHARMA operating profit margin trend?
JOHNPHARMA has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is JOHNPHARMA quarterly performance?
Recent quarterly performance shows Johnson Pharmacare Ltd YoY Sales Growth of N/A% and YoY Profit Growth of N/A%.
What is the institutional holding pattern in JOHNPHARMA?
JOHNPHARMA has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Johnson Pharmacare Ltd stock.